Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10611760
Therapeutic compounds as inhibitors of the orexin-1 receptor
granted -
US 10612025
Antisense oligonucleotides for the treatment of eye disease
granted -
US 10610486
Sustained release formulation of a non-steroidal anti-inflammatory drug
granted -
US 10611758
N-((het)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors
granted -
US 10614684
Treatment of kidney diseases associated with elevated AVP
granted -
US 10612045
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10612027
Modified double-stranded RNA agents
granted -
US 10611998
Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
granted -
US 10611827
Non-human primate-derived pan-ebola and pan-filovirus monoclonal antibodies directed against envelope glycoproteins
granted -
US 10611816
Anti-KRAS-G12D T cell receptors
granted -
US 10611815
T cell receptors recognizing MHC class II-restricted MAGE-A3
granted -
US 10611851
Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
granted -
US 10611880
Oxime cross-linked biocompatible polymer hydrogels and methods of use thereof
granted -
US 10611768
P2X3 and/or P2X2/3 compounds and methods
granted -
US 10610583
Methods and compositions for treating glioma and medulloblastoma brain tumors using the zika virus
granted -
US 10611744
Highly purified pharmaceutical grade tasimelteon
granted -
US 10610597
Polycarbonates bearing aromatic N-heterocycles for drug delivery
granted -
US 10610563
Use of ubiquitin-proteasome system inhibitors for treatment of tumors associated with neurofibromatosis type-2
granted -
US 10610535
Diarylpropionitrile therapy for treatment of multiple sclerosis
granted -
US 10612024
Modified double-stranded RNA agents
granted -
US 10610527
Methods for treating immunodeficiency disease
granted -
US 10610533
Methods of treating oral mucositis
granted -
US 10610493
Detoxification using nanoparticles
granted -
US 10610497
Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.